Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2008 Jul 18;49(12):5526–5531. doi: 10.1167/iovs.08-2196

Figure 3.

Figure 3

CBD or NBMPR, but not HU210, inhibits [3H]adenosine uptake in retinal microglial cells. Cells were pretreated with NBMPR (0, 0.02, 0.1, and 0.5 μM), CBD (0.5 μM), NBMPR combined with CBD, or HU210 (1 μM) for 30 min at 37°C, and uptake of 0.5 μCi [3H]adenosine over a period of 1 min was assayed. Nonspecific uptake, determined in the presence of 1 mM adenosine, was subtracted from each data point (n ≥ 5). *, P< 0.005, **, P< 0.05, compared with the vehicle control (one-way ANOVA followed by the post hoc test (Fisher's PLSD).